Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Key Ratios

Price & Volume
Recent Price$0.46
52 Week High$3.46
52 Week Low$0.32
Average Volume (30 days)1.13M
Share Related Items
Market Cap$16.53M
Shares Outstanding35.85M
Dividend Information
Yield %--
Annual Dividend--
Payout Ratio-181.8%
Financial Strength
Quick Ratio (MRQ)2.2
Current Ratio (MRQ)3.3
LT Debt/Capital (MRQ)38%
Total Debt/Equity (MRQ)106%
Valuation Ratios
Price/Earnings (TTM)--
Price/Sales (TTM)100.17
Price/Book (MRQ)2.20
Price/Cash Flow (TTM)--
Per Share Data
Earnings (TTM)($0.55)
Sales (TTM)$0.00
Book Value (MRQ)$0.21
Cash Flow (TTM)($0.45)
Cash (MRQ)$0.46
Management Effectiveness
Return on Equity (TTM)-139.6%
Return on Assets (TTM)-67.0%
Return on Investment (TTM)-69.2%
Gross Margin (TTM)--
EBIT Margin (TTM)-7,647.3%
Profit Margin (TTM)--